Sarah Vodopest, MD
Rheumatology · Overland Park, KSNPI 1780946194
Payments from drug & device makers
Across 213 payments — averaging $19.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$755
- Amgen$750
- UCB, Inc.$512
- Novartis$361
- Johnson & Johnson$324
- Pfizer$272
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,239100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 39 | $755 |
| Amgen(2 entities) | 36 | $750 |
| UCB, Inc. | 24 | $512 |
| Novartis | 20 | $361 |
| Johnson & Johnson | 17 | $324 |
| Pfizer | 17 | $272 |
| AstraZeneca(2 entities) | 7 | $152 |
| Acadia Pharmaceuticals Inc | 1 | $120 |
| GSK | 6 | $112 |
| Boehringer Ingelheim | 4 | $104 |
| Genentech USA, Inc. | 6 | $90 |
| Radius Health, Inc. | 3 | $88 |
| E.r. Squibb & Sons, L.L.C. | 5 | $73 |
| Lilly USA, LLC | 5 | $72 |
| Fresenius Kabi USA, LLC | 3 | $63 |
| Sanofi | 3 | $59 |
| Bristol Myers Squibb | 3 | $46 |
| Organon | 2 | $45 |
| Mallinckrodt Hospital Products Inc. | 2 | $38 |
| Sobi, Inc | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 2 | $31 |
| Grifols USA, LLC | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Antares Pharma, Inc. | 1 | $16 |
| Hospira, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUPLAZID$120
How this compares
$4,239 in reported general payments places this provider in the 65th percentile of 49 rheumatology providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Enbrel SureclickEtanercept | 26 | $185,758 |
| Orencia ClickjectAbatacept | 22 | $123,671 |
| Hydroxychloroquine Sulfate | 207 | $6,976 |
| MethotrexateMethotrexate Sodium | 157 | $4,779 |
| Pilocarpine Hcl | 14 | $1,748 |
| Sulfasalazine DrSulfasalazine | 31 | $1,549 |
| Leflunomide | 21 | $1,310 |
| Prednisone | 111 | $998 |
| Celecoxib | 30 | $986 |
| Sulfasalazine | 29 | $812 |
| Tramadol Hcl | 68 | $643 |
| Alendronate Sodium | 63 | $514 |
| Nifedipine ErNifedipine | 26 | $468 |
| Methotrexate SodiumMethotrexate Sodium/Pf | 22 | $386 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $246 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Overland Park
- James AndersonOverland Park$75K
- Stephen RuhlmanOverland Park$32K
- Arnold KatzOverland Park$25K
- Aruna BarathamOverland Park$23K
- Shirley WangOverland Park$19K
- Jonathan AmosOverland Park$4K
- Carrie MihordinOverland Park$4K
- Christopher KoenigOverland Park$391
- Shadi ShahouriWichita$635K
- Basit MalikHutchinson$186K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.